Chylomicronaemia--current diagnosis and future therapies.
about
The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain.Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial resultsWhat can we learn about lipoprotein metabolism and coronary heart disease from studying rare variants?The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study.Pharmacogenetics of Lipid-Lowering Agents: Precision or Indecision Medicine?Lomitapide for the treatment of hypertriglyceridemia.Genetics of Triglycerides and the Risk of Atherosclerosis.ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.A 1-month-old infant with chylomicronemia due to GPIHBP1 gene mutation treated by plasmapheresis.A Pressure-dependent Model for the Regulation of Lipoprotein Lipase by Apolipoprotein C-II.Clinical, biochemical and molecular analysis of two infants with familial chylomicronemia syndrome.Severe hypertriglyceridemia due to two novel loss-of-function lipoprotein lipase gene mutations (C310R/E396V) in a Chinese family associated with recurrent acute pancreatitisMultidimensional regulation of lipoprotein lipase: impact on biochemical and cardiovascular phenotypes.A 19 year follow-up of a woman with lipoprotein lipase deficiency treated with biliopancreatic diversion.Chylomicronemia risk factors ranked by importance for the individual and community in 108 711 women and men.Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.The burden of familial chylomicronemia syndrome from the patients' perspective.Identifying suspected familial chylomicronemia syndrome.
P2860
Q36585939-94CA208A-6476-4757-9E7E-D0DF53A9129AQ36731776-11831347-F023-4A59-B650-2122E7728090Q36760799-53527A90-4089-4BFA-AED9-8131635C81B4Q38558041-15931CD6-E9AC-4C34-BF1E-F826F5F09D9BQ38780996-B20F86FF-F709-4F80-8521-2B11CA0BF784Q38992251-7BD002A3-B34E-46ED-9B97-97DCBF90357DQ39324048-62F044D9-CAB5-48CE-B46F-AC464DAB9BB4Q39614082-5B5664D0-AF6D-4B04-9691-2FA6A530D374Q40059592-37FD49CE-573D-439B-996C-49F1EEDD52CCQ40887732-AB9DFBD8-905A-48C5-BB39-DA55B307B070Q41139281-89B7C43F-7B6B-4E3F-97CF-325DE84D4842Q41471278-6EEFDBAE-AB48-411E-AD65-7F909B99EDC7Q42400268-ABEEFBF2-BB11-4ADD-823A-524BC6D74832Q43113710-CF1CD995-CA3C-4FA9-963B-AE805D1A7975Q48318089-3B9B6D2E-A3A1-433D-8204-E3302ACBFFDFQ50183430-D60320CF-192F-4861-9904-186F295D4F95Q53098694-B28DF660-6CA8-4175-99D4-715E8F6C660AQ55244214-C03AC266-1FD4-4178-A300-EAF2FD513CC5
P2860
Chylomicronaemia--current diagnosis and future therapies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Chylomicronaemia--current diagnosis and future therapies.
@en
type
label
Chylomicronaemia--current diagnosis and future therapies.
@en
prefLabel
Chylomicronaemia--current diagnosis and future therapies.
@en
P2860
P356
P1476
Chylomicronaemia--current diagnosis and future therapies.
@en
P2093
Amanda J Brahm
P2860
P2888
P304
P356
10.1038/NRENDO.2015.26
P577
2015-03-03T00:00:00Z
P5875
P6179
1018813491